Scioto Biosciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $13M

  • Investors
  • 13

Scioto Biosciences General Information

Description

Operator of a clinical-stage biotech company intended to be used for research, discovery and development in the field of microbiome therapeutics. The company provides prime therapeutic bacteria that have the potential to advance healing for various diseases associated with the central nervous system and gastrointestinal tract through a synbiotic-activated formulation for optimized function and increased oxytocin levels, enabling researchers to get higher efficacy, improved GI survival and mucosal thickening in severe gut injury animal models.

Contact Information

Website
www.sciotobiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9800 Crosspoint Boulevard
  • Indianapolis, IN 46256
  • United States
+1 (317)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 9800 Crosspoint Boulevard
  • Indianapolis, IN 46256
  • United States
+1 (317)

Scioto Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scioto Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 01-May-2026 $13M Completed Clinical Trials - Phase 2
10. Later Stage VC 01-Jan-2024 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series B2) 12-Nov-2021 Completed Pre-Clinical Trials
8. Early Stage VC (Series B1) 10-Aug-2020 Completed Pre-Clinical Trials
7. Grant 21-Aug-2019 Completed Clinical Trials - Phase 1
6. Early Stage VC (Series A) 21-Dec-2018 Completed Clinical Trials - Phase 1
5. Grant 01-Aug-2017 Completed Startup
4. Grant 01-May-2017 Completed Startup
3. Grant 27-Oct-2016 $25K Completed Startup
2. Accelerator/Incubator Completed Startup
To view Scioto Biosciences’s complete valuation and funding history, request access »

Scioto Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A Prime
To view Scioto Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Scioto Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotech company intended to be used for research, discovery and development in the field of
Drug Delivery
Indianapolis, IN
10 As of 2024

Boston, MA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Scioto Biosciences Competitors (37)

One of Scioto Biosciences’s 37 competitors is Entrada Therapeutics, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Entrada Therapeutics Formerly VC-backed Boston, MA
Enterome Venture Capital-Backed Paris, France
Viome Life Sciences Venture Capital-Backed Bellevue, WA
Vaiomer Accelerator/Incubator Backed Toulouse, France
4D pharma Corporation Leeds, United Kingdom
You’re viewing 5 of 37 competitors. Get the full list »

Scioto Biosciences Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 5

    Pending

  • Expiring in next 12 mo

Scioto Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021207625-A1 Methods for treating or ameliorating autism and related disorders Pending 13-Jan-2020
CA-3164170-A1 Methods for treating or ameliorating autism and related disorders Pending 13-Jan-2020
EP-4090164-A1 Methods for treating or ameliorating autism and related disorders Pending 13-Jan-2020
EP-4090164-A4 Methods for treating or ameliorating autism and related disorders Pending 13-Jan-2020
JP-2026083279-A Methods for treating or ameliorating autism and related disorders Pending 13-Jan-2020 A61K35/747
To view Scioto Biosciences’s complete patent history, request access »

Scioto Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scioto Biosciences Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Michigan Capital Network Venture Capital Minority
Thornapple River Capital Venture Capital Minority
Genome & Company Corporation Minority
Indiana 21st Century Research and Technology Fund Government Minority
National Institute of General Medical Sciences Government
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Scioto Biosciences FAQs

  • When was Scioto Biosciences founded?

    Scioto Biosciences was founded in 2016.

  • Where is Scioto Biosciences headquartered?

    Scioto Biosciences is headquartered in Indianapolis, IN.

  • What is the size of Scioto Biosciences?

    Scioto Biosciences has 10 total employees.

  • What industry is Scioto Biosciences in?

    Scioto Biosciences’s primary industry is Drug Delivery.

  • Is Scioto Biosciences a private or public company?

    Scioto Biosciences is a Private company.

  • What is the current valuation of Scioto Biosciences?

    The current valuation of Scioto Biosciences is .

  • What is Scioto Biosciences’s current revenue?

    The current revenue for Scioto Biosciences is .

  • How much funding has Scioto Biosciences raised over time?

    Scioto Biosciences has raised $28.5M.

  • Who are Scioto Biosciences’s investors?

    Michigan Capital Network, Thornapple River Capital, Genome & Company, Indiana 21st Century Research and Technology Fund, and National Institute of General Medical Sciences are 5 of 13 investors who have invested in Scioto Biosciences.

  • Who are Scioto Biosciences’s competitors?

    Entrada Therapeutics, Enterome, Viome Life Sciences, Vaiomer, and 4D pharma are some of the 37 competitors of Scioto Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process